Industry: The market of traditional Chinese medicine formula granules will accelerate the expansion, approaching the 100 billion yuan mark

Traditional Chinese medicine formula granules are the inheritance, development and innovation of traditional Chinese medicine pieces.
They are made of traditional Chinese medicine pieces that meet the processing specifications as raw materials, and are made by modern pharmaceutical production technologies such as water extraction, concentration, drying, and granulation.
All are consistent with Chinese herbal medicine
.
The traditional Chinese medicine formula granules have the advantages of safety and effectiveness, stable and controllable quality, and convenient taking, which are more in line with the fast-paced life of modern people
.
Compared with Japanese Kampo granules, although China's traditional Chinese medicine formula granules industry started late, it has always been encouraged and supported by national policies, and the industry has gradually become standardized.
Especially in 2021, with the completion of the pilot work of traditional Chinese medicine formula granules, the market will be released The operation has driven the development of the traditional Chinese medicine formula granule industry to gradually mature
.
At the same time, the industry quality standards are also improving.
As of March 2022, the state has announced 196 national standards for formula granules.
The industry believes that with the successive release of national standards for subsequent formula granules and the successive listing of compliant products laid out by pharmaceutical companies, traditional Chinese medicine formula The particle industry will usher in a broad space for development
.
So, how much expansion can the market of traditional Chinese medicine formula granules usher in? Referring to the stipulations in the announcement of Shandong Medical Insurance Bureau on the "Notice on Doing a Good Job in Medical Insurance Payment of Traditional Chinese Medicine Formula Granules (Trial)" Public Solicitation of Opinions, that is, "the usage amount of traditional Chinese medicine formula granules in the same medical institution shall not exceed 30% of the TCM decoction pieces.
”, the industry expects that the market volume of TCM formula granules will reach at least 20-30% of TCM decoction pieces
.
"At present, the market size of Chinese herbal medicine pieces is about 200 billion yuan.
Regardless of factors such as centralized procurement and price reduction, it is estimated that the volume of Chinese medicine formula granules will reach 64-108 billion yuan
.
" It is worth mentioning that, compared with Chinese medicine pieces, the price of Chinese medicine formula granules Generally high, especially under the new standard, pharmaceutical companies that produce traditional Chinese medicine formula granules are facing higher requirements, and various testing costs will increase significantly, and the ex-factory price is expected to rise, in order to hedge against rising standards and upstream cost pressures
.
In order to promote the development of traditional Chinese medicine formula granules, on December 30, 2021, the two departments jointly issued the "Guiding Opinions on Medical Insurance Supporting the Inheritance and Innovation of Traditional Chinese Medicine", which encourages the inclusion of traditional Chinese medicine formula granules purchased by public medical institutions into the provincial centralized pharmaceutical procurement platform.
Online transactions to promote open and transparent transactions
.
In addition to encouraging the inclusion of traditional Chinese medicine formula granules into medical insurance at the national level, local governments have already taken action.
For example, Yunnan, Zhejiang, Hubei, Shandong and other places have included traditional Chinese medicine formula granules into provincial medical insurance, but there are also many places that include traditional Chinese medicine formula granules.
A place to kick out of Medicare coverage
.
In general, the progress of medical insurance varies from place to place
.
The industry believes that with the gradual standardization of national medical insurance payment standards and the continuous enhancement of terminal payment capabilities, it will further drive the growth of demand for traditional Chinese medicine granules
.
In terms of the centralized procurement policy that the industry is concerned about, in August 2021, the National Medical Insurance Bureau stated in response to the "Suggestions on Accelerating the Entry of Chinese Medicines and Formula Granules into Centralized Procurement", "The next step will be to accelerate the inclusion of Chinese patent medicines and formula granules in centralized procurement.
" , it can be seen that the centralized collection of formula particles is a matter of time
.
The industry believes that the conditions for the national centralized procurement of traditional Chinese medicine granules are not mature, and it is not ruled out that some provinces and cities will explore the centralized procurement of varieties with large quantities and high prices.
It will be similar to Chinese patent medicine to ease
.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyone
.